Page last updated: 2024-08-17

cytidine monophosphate and Muscular Dystrophy, Duchenne

cytidine monophosphate has been researched along with Muscular Dystrophy, Duchenne in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ball, V; Betts, CA; Gait, MJ; Godfrey, C; Hammond, SM; Healicon, R; Manzano, R; McClorey, G; Merritt, TM; Muses, S; O'Donovan, L; Tyler, D; van Westering, T; Wells, DJ; Wells, KE; Wood, MJ	1

Other Studies

1 other study(ies) available for cytidine monophosphate and Muscular Dystrophy, Duchenne

Article	Year
Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment. Human molecular genetics, 2019, 02-01, Volume: 28, Issue:3 Topics: Animals; Cardiomyopathy, Dilated; Carnitine O-Palmitoyltransferase; Connective Tissue Growth Factor; Cytidine Monophosphate; Disease Models, Animal; Dystrophin; Exons; Genetic Therapy; Heart; Male; Mice; Mice, Inbred mdx; Mixed Function Oxygenases; Morpholinos; Muscular Dystrophy, Duchenne; Myocardium; NADPH Oxidase 4; Oligonucleotides, Antisense; Peptides; Phenotype; Stroke Volume; Uncoupling Protein 3; Ventricular Function, Right	2019

Article

Year

Cmah-dystrophin deficient mdx mice display an accelerated cardiac phenotype that is improved following peptide-PMO exon skipping treatment.

Human molecular genetics, 2019, 02-01, Volume: 28, Issue:3

Topics: Animals; Cardiomyopathy, Dilated; Carnitine O-Palmitoyltransferase; Connective Tissue Growth Factor; Cytidine Monophosphate; Disease Models, Animal; Dystrophin; Exons; Genetic Therapy; Heart; Male; Mice; Mice, Inbred mdx; Mixed Function Oxygenases; Morpholinos; Muscular Dystrophy, Duchenne; Myocardium; NADPH Oxidase 4; Oligonucleotides, Antisense; Peptides; Phenotype; Stroke Volume; Uncoupling Protein 3; Ventricular Function, Right

2019